Isis Pharmaceuticals Bags USD 35 M Up Front in Deal with GSK
By Debbie Tranter
Pharma Deals Review: Vol 2010 Issue 4 (Table of Contents)
Published: 26 May-2010
DOI: 10.3833/pdr.v2010.i4.1333 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
GSK has entered into an alliance with Isis Pharmaceuticals to pursue and develop new therapeutics against targets for rare and serious diseases...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS